The efficacy and safety of XELOX plus bevacizumab with oxaliplatin stop-and-go strategy in first-line treatment for metastatic colorectal cancer: CCOG 0902 study

被引：0
|
作者：
Watanabe, Takuya
Nakayama, Goro
Ishigure, Kiyoshi
Hayashi, Naomi
Yaguchi, Toyohisa
Kojima, Hiroshi
Tsuboi, Kenji
Ito, Akihiro
Deguchi, Tomohiro
Sekiya, Masanori
Tanaka, Chie
Ando, Yuichi
Ohashi, Norifumi
Kodera, Yasuhiro
机构：
[1] Komaki City Hosp, Komaki, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi 4648601, Japan
[3] Konan Kosei Hosp, Konan, Aichi, Japan
[4] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[5] Kainan Hosp, Yayomi, Japan
[6] Aichi Canc Ctr Hosp, Okazaki, Aichi, Japan
[7] Tosei Hosp, Seto, Japan
[8] Toki City Hosp, Toki, Gifu, Japan
[9] Tajimi Prefectual Hosp, Tajimi, Japan
[10] Nakatsugawa City Hosp, Nakatsugawa, Japan
[11] Nagoya Grad Sch Med, Nagoya, Aichi, Japan
[12] Nagoya Univ Hosp, Nagoya, Aichi, Japan
[13] Aichi Med Univ, Nagakute, Aichi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.564
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
564
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer
    Doi, Toshihiko
    Boku, Narikazu
    Kato, Ken
    Komatsu, Yoshito
    Yamaguchi, Kensei
    Muro, Kei
    Hamamoto, Yasuo
    Sato, Atsushi
    Koizumi, Wasaburo
    Mizunuma, Nobuyuki
    Takiuchi, Hiroya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (10) : 913 - 920
  • [22] Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer - The PHOENiX Trial
    Matsui, Takanori
    Nagata, Naoki
    Hirata, Keiji
    Okazaki, Satoshi
    Sato, Sumito
    Nakamura, Masato
    Kim, Homin
    Oba, Koji
    Sakamoto, Junichi
    Mishima, Hideyuki
    ANTICANCER RESEARCH, 2016, 36 (07) : 3437 - 3443
  • [23] Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: Results of the TREE study
    Hochster, Howard S.
    Hart, Lowell L.
    Ramanathan, Ramesh K.
    Childs, Barrett H.
    Hainsworth, John D.
    Cohn, Allen L.
    Wong, Lucas
    Fehrenbacher, Louis
    Abubakr, Yousif
    Saif, M. Wasif
    Schwartzberg, Lee
    Hedrick, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3523 - 3529
  • [24] PHASE II STUDY OF BEVACIZUMAB plus OXALIPLATIN PLUS CAPECITABINE FOLLOWED BY BEVACIZUMAB plus ERLOTINIB AS FIRST-LINE TREATMENT IN METASTATIC COLORECTAL CANCER
    Munoz, A.
    Pericay, C.
    Llorente, B.
    Alonso, V
    Duenas, R.
    Roca, J.
    Rivera, F.
    Falco, E.
    Alvarez, I
    Salud, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 73 - 74
  • [25] Efficacy and safety of XELIRI plus cetuximab versus XELOX plus cetuximab in first-line treatment of metastatic colorectal cancer (mCRC)
    Ocvirk, J.
    Boc, M.
    Rebersek, M.
    Mesti, T.
    Ebert, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Capecitabine plus oxaliplatin (XELOX): Clinical efficacy and safety in the first-line treatment for metastic gastric cancer
    Alu', M.
    Leonardi, V
    Laudani, A.
    Palmisano, V
    Giresi, A.
    Pepe, A.
    Arcuri, C.
    Savio, G.
    Rondello, G.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2006, 17 : XI54 - XI54
  • [27] Capecitabine plus oxaliplatin (XELOX):: Clinical efficacy and safety in the first-line treatment for metastic gastric cancer
    Alu, Massimiliano
    Leonardi, Vita
    Laudani, Agata
    Palmisano, Valentina
    Giresi, Armando
    Pepe, Alessio
    Arcuri, Carmen
    Savio, Giuseppina
    Manuguerra, Giovanna
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2006, 17 : 324 - 324
  • [28] XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
    Cassidy, J
    Tabernero, J
    Twelves, C
    Brunet, R
    Butts, C
    Conroy, T
    Debraud, F
    Figer, A
    Grossmann, J
    Sawada, N
    Schöffski, P
    Sobrero, A
    Van Cutsem, E
    Diaz-Rubio, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2084 - 2091
  • [29] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    Ozcelik, M.
    Odabas, H.
    Ercelep, O.
    Yuksel, S.
    Mert, A. G.
    Aydin, D.
    Surmeli, H.
    Isik, D.
    Isik, S.
    Oyman, A.
    Ustaalioglu, B. B. Oven
    Aliustaoglu, M.
    Gumus, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (06): : 617 - 624
  • [30] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    M. Ozcelik
    H. Odabas
    O. Ercelep
    S. Yuksel
    A. G. Mert
    D. Aydin
    H. Surmeli
    D. Isik
    S. Isik
    A. Oyman
    B. B. Oven Ustaalioglu
    M. Aliustaoglu
    M. Gumus
    Clinical and Translational Oncology, 2016, 18 : 617 - 624
12345